Modulation of Oxidative Stress in Heart Disease

A. Regulation of Oxidative Stress
1. Impact of genetic and epigenetic factors on the oxidative stress in cardiovasculardisease
2. Role of aging and metabolic disease in oxidative stress of heart
3. Role of monoamine oxidases in heart diseases
4. Role of miRNA in oxidative stress induced heart diseases
5. Modulation of Oxidative (stressed) Heart Disease by Uncoupling Proteins
6. Redox regulation in heart by ion channels
7. Molecular regulators in ROS mediated cardiac diseases.
8. The inflammatory stress that follows preceded oxidative stresses in the pathogenesisof heart diseases
9. Metabolic signatures of redox-dependent cardiovascular disease.
10. Role of heat shock proteins in oxidative stress induced heart diseases.
B. Pathophysiology of Oxidative Stress
11. Oxidative stress in metabolic syndrome : experimental model of biomarkers
12. Oxidative stress as a critical determinant of adult cardiac progenitor cell-fatedecisions
13. Role of oxidative stress in hyperhomocysteinemia-induced heart disease
14. Oxidative Stress and the Aging Heart
15. Basic mechanisms of ischemia/reperfusion injury leading to cellular and tissuedamage
16. Oxidative stress in congenital heart defects.
17. Nitrosative stress and cardiogenesis: Cardiac remodeling perturbs embryonicmetabolome
18. Oxidative Stress and Mitochondrial Dysfunction in Heart Diseases
19. Role of oxidative stress, mitochondrial dysfunction and autophagy in cardiovasculardisease: Its pathogenesis and amelioration by different small natural molecules
20. Regulation of cardiac ion channels in stress related heart diseases
21.In silico perspectives of the mechanism of oxidative stress during the onset of heartdisease.
22.Biomarkers of oxidative stress and endothelial dysfunction in the elderly: oxidizedLDL versus LDL oxidizability
C. Prevention & therapeutics
23. Restoring

Dr Sajal Chakraborti is a Professor of Biochemistry at the University of Kalyani, West Bengal, India. He completed his PhD at Calcutta University, Kolkata, India and his DSc at the University of Kalyani. He also pursued postdoctoral research at Johns Hopkins University, Baltimore; University of Utah, Salt Lake City; and New York Medical College, New York as a Fulbright Fellow. He visited the University of Florida, Gainesville, Florida, where he conducted research on f beta-adrenergic receptor activation in heart disease. His research mainly deals with the role of vasoactive agents in regulating vascular tone under oxidant and calcium signaling phenomena. He has been engaged in biochemistry teaching and research for the past 40 years (email: saj_chakra@rediffmail.com).

Dr Naranjan S Dhalla is a Distinguished Professor at the University of Manitoba, Winnipeg, Canada. His expertise includes the subcellular and molecular basis of heart function in health and disease. He has been engaged in multidisciplinary cardiology research and education for over 50 years. He is currently the Editor-in-chief of Molecular and Cellular Biochemistry (Springer) (email: NSDhalla@sbrc.ca).

Dr Madhu Dixit is a National Chair Fellow of the Translational Health Science and Technology Institute, Faridabad, Haryana, India. She has contributed to the general area of biochemical pharmacology with a special interest in cardiovascular pharmacology and redox biology. Dr Dixit has been engaged in research, especially on drug discovery and development, for over 40 years (email: rmadhudikshit@gmail.com).

Dr Nirmal K Ganguly, a distinguished biotechnologist and former Director General of the Indian Council of Medical Research (ICMR), is associated with Global Health Strategies, New Delhi, India. One important aspect of his research is the understanding of occupational, environmental and nutritional aspects of heart disease. In 2008 he was